BioAgeDiagnostics adds Dr. Stuart M. Diamond to medical advisory board

BioAgeDiagnostics appointed board-certified longevity physician and surgeon Dr. Stuart M. Diamond as Medical Advisor on July 28, 2026, to help expand its precision longevity diagnostics platform. The move is meant to strengthen the company’s clinical network as it pushes biomarker-guided longevity medicine across Europe, the Middle East, Asia and other markets.

Why it matters: - BioAgeDiagnostics is trying to move longevity medicine from broad wellness claims toward clinically actionable diagnostics. - Dr. Stuart M. Diamond’s background in urology, surgery and longevity medicine adds clinical credibility to that push. - The appointment supports BioAgeDiagnostics’ plan to expand adoption of precision longevity tools among physicians, clinics and healthcare systems worldwide.

What happened: - BioAgeDiagnostics announced on July 28, 2026, that Dr. Stuart M. Diamond, MD, FACS, has joined the company as Medical Advisor. - The company is based in Charlottenlund, Gentofte, Denmark. - Dr. Diamond is a board-certified urologist, surgeon and certified longevity physician. - Dr. Diamond said objective biomarkers will increasingly guide clinical decision-making in longevity medicine. - Dr. Diamond said advanced molecular diagnostics can help identify biological decline, personalize interventions and monitor outcomes over time.

The details: - Dr. Diamond will provide strategic clinical guidance across BioAgeDiagnostics’ expanding longevity diagnostics portfolio. - BioAgeDiagnostics said the role is intended to keep its solutions clinically relevant, scientifically rigorous and aligned with physician and longevity-practitioner needs. - Dr. Diamond currently serves in a leading medical role at NDA Medical Spa. - Dr. Diamond helped expand NDA Medical Spa beyond aesthetic medicine into a longevity and preventive health model. - Dr. Diamond drove the creation of the Longevity Institute at NDA Aesthetics. - The institute integrates advanced diagnostics, metabolic optimization, hormone health and performance medicine. - Dr. Diamond has earned multiple Top Doctor recognitions. - Dr. Diamond advises medical, wellness and aesthetic organizations on clinical innovation, patient safety and evidence-based implementation of emerging technologies. - Dr. Diamond is pursuing a master’s degree in Longevity Science through the Geneva Institute of Longevity Science. - Dr. Diamond has also collaborated with Duke University-affiliated partners on VO₂ max testing and metabolic assessments.

Between the lines: - BioAgeDiagnostics is building a broader precision longevity platform, not just a single test. - The platform includes biological age assessment, organ-specific resilience analysis, genetic testing, microbiome diagnostics and advanced therapeutic solutions. - The company’s strategy depends on clinician partnerships to make longevity diagnostics feel usable in everyday care, not just research settings. - CEO Bettina van Wylich-Muxoll framed Dr. Diamond’s appointment as part of that network-building effort.

What's next: - BioAgeDiagnostics plans to continue expanding its global clinical network. - The company said it will keep bringing next-generation longevity diagnostics to physicians, clinics and healthcare systems worldwide. - BioAgeDiagnostics is aiming to accelerate clinically actionable longevity medicine across Europe, the Middle East, Asia and beyond. - Dr. Diamond’s role is expected to support the company as it broadens its precision longevity offering.

The bottom line: - BioAgeDiagnostics is betting that experienced clinicians will help turn longevity diagnostics into a mainstream medical workflow.